SLNO Soleno Therapeutics Inc

$44.95

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California.

Website: https://soleno.life

Sector
LIFE SCIENCES
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1484565
Address
1235 RADIO ROAD, SUITE 110, REDWOOD CITY, CA, US
Valuation
Market Cap
$3.21B
P/E Ratio
nan
PEG Ratio
0.00
Price to Book
13.09
Performance
EPS
$-4.38
Dividend Yield
—
Profit Margin
0.00%
ROE
-87.40%
Technicals
50D MA
$54.36
200D MA
$50.71
52W High
$74.00
52W Low
$36.93
Fundamentals
Shares Outstanding
46M
Target Price
$102.12
Beta
-2.29

SLNO EPS Estimates vs Actual

● Estimated
● Actual

SLNO News & Sentiment

Nov 18, 2025 • Benzinga NEUTRAL
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations - Agilon Health ( NYSE:AGL ) , Coty ( NYSE:COTY )
NEW YORK, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. ( NYSE:AGL ) , Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) , AVITA Medical, Inc. ( NASDAQ:RCEL ) , and Coty, ...
Nov 16, 2025 • Benzinga NEUTRAL
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. ( NASDAQ: SLNO ) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Soleno Therapeutics ( NASDAQ:SLNO )
NEWTOWN, Pa., Nov. 16, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Soleno Therapeutics, Inc. ( "Soleno" or "the Company" ) ( NASDAQ:SLNO ) , resulting from allegations of providing potentially ...
Nov 14, 2025 • Benzinga NEUTRAL
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law - Soleno Therapeutics ( NASDAQ:SLNO )
SAN DIEGO, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) focused on whether Soleno and certain of its executives made false and/or ...
Nov 13, 2025 • Benzinga NEUTRAL
Soleno Therapeutics ( SLNO ) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% - Hagens Berman - Soleno Therapeutics ( NASDAQ:SLNO )
SAN FRANCISCO, Nov. 13, 2025 ( GLOBE NEWSWIRE ) -- Investors in Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) saw the price of their shares tumble $18.78 ( -28% ) after the company reported disappointing information about VYKAT™ XR, a once-daily oral tablet intended to treat hyperphagia.
Nov 11, 2025 • Benzinga SOMEWHAT-BULLISH
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. ( SLNO ) Shareholders Who Have Incurred Losses - Soleno Therapeutics ( NASDAQ:SLNO )
SAN DIEGO, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. ( NASDAQ:SLNO ) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to ...
Nov 11, 2025 • Benzinga SOMEWHAT-BULLISH
Why Is Soleno Therapeutics Stock Surging Tuesday? - Soleno Therapeutics ( NASDAQ:SLNO )
Soleno Therapeutics Inc. ( NASDAQ:SLNO ) stock rose Tuesday after the company said its board had approved a share repurchase program and entered into a $100 million accelerated share repurchase ( ASR ) agreement with Jefferies Financial Group Inc.'s ( NYSE:JEF ) Jefferies LLC to buy back its ...
Sentiment Snapshot

Average Sentiment Score:

0.094
50 articles with scored sentiment

Overall Sentiment:

Neutral

SLNO Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
0.55 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.64
  • Whisper: —
  • Surprise %: 85.9%
May 07, 2025
Mar 31, 2025 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.95
  • Estimate: $-0.93
  • Whisper: —
  • Surprise %: -2.4%
Feb 27, 2025
Dec 31, 2024 (Pre market)
-0.19 Surprise
  • Reported EPS: $-1.27
  • Estimate: $-1.08
  • Whisper: —
  • Surprise %: -17.9%
Nov 06, 2024
Sep 30, 2024 (Pre market)
-1.2 Surprise
  • Reported EPS: $-1.83
  • Estimate: $-0.63
  • Whisper: —
  • Surprise %: -190.5%
Aug 07, 2024
Jun 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $-0.57
  • Estimate: $-0.60
  • Whisper: —
  • Surprise %: 5.0%
May 09, 2024
Mar 31, 2024 (Post market)
-0.22 Surprise
  • Reported EPS: $-0.59
  • Estimate: $-0.37
  • Whisper: —
  • Surprise %: -59.5%
Mar 06, 2024
Dec 31, 2023 (Post market)
-0.06 Surprise
  • Reported EPS: $-0.33
  • Estimate: $-0.27
  • Whisper: —
  • Surprise %: -22.2%
Nov 07, 2023
Sep 30, 2023 (Pre market)
-0.37 Surprise
  • Reported EPS: $-0.95
  • Estimate: $-0.58
  • Whisper: —
  • Surprise %: -63.8%
Aug 08, 2023
Jun 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.81
  • Estimate: $-0.83
  • Whisper: —
  • Surprise %: 2.4%

Financials